Could ‘around the pill’ solutions be the key to effective diabetes management?
Published in pharmaphorum July 2015 by Julie Denny
Research with patients shows that they have particular needs at specific stages, from diagnosis to longer-term disease management, that pharma and technology could address.
In the crowded type 2 diabetes market, pharma companies need to find other ways, beyond blood glucose control, to differentiate their brands. In an effort to stand out, players such as Janssen have developed 'around the pill' support programmes that aim to help patients address the health and lifestyle issues which are causing them to struggle to maintain management of their disease.
Critical to the success of these programmes is a strong understanding of diabetes patients, their needs and behaviours, the obstacles they face at each stage in the patient journey and the levers that may bring about a change in behaviour.
So what do patients with diabetes think about their disease and what do they need to help them improve their health? An independent online and mobile market research study1 of 2,500 patients across Europe identified three key areas where patients need greater support:
2. Compliance with treatment
3. Long-term lifestyle management
Sign up to receive Rapport
Rapport is our e-newsletter and online resource for sharing our expertise and experience in global healthcare market research. Sign up here »